Expand our pipeline. Expand our markets.

Pioneers at the convergence point of generic and specialty pharmaceuticals.

World-class manufacturing, global reach, and sharing financial resources.

Expand our U.S. Specialty Generics business through investment in our sustainable pipeline of high-technology products and leverage these pipeline investments through expanding our sales and marketing platform across new markets.

We aspire to lead and define the ever-evolving convergence between generics and specialty pharmaceuticals. By providing greater access to such medications, we hope to improve the health and quality of life for millions of Americans.

As we pursue our vision, Alvogen's assets include full-service manufacturing of Rx and OTC products with a sterling reputation for quality, multinational affiliates producing and marketing over 400 generic and OTC products in Europe, the Middle East and Africa, and strong financial resources to support the growth of our constantly expanding pipeline.
